title: CKD in HIV-infected patients other than HIV-associated nephropathy.
abstract: A spectrum of kidney diseases in HIV-infected patients has been reported both before and after the introduction of highly active antiretroviral therapy (HAART). Kidney syndromes affecting HIV-infected patients include CKD as well as proteinuria, nephrotic syndrome, and acute nephritic syndrome. Thrombotic microangiopathy should be considered in patients with kidney disease and typical clinical characteristics. As the HIV-infected population ages, there is increased concern regarding the incidence of vascular and metabolic disease, leading to an increased burden of CKD. Although HIV-associated nephropathy is still the major cause of nephrotic syndrome in HIV-infected patients, immune complex glomerulonephritis (ICGN) still comprises a substantial proportion of the disease burden, especially in people of European origin. Genetic investigations into the underpinnings of the various histologic expressions of HIV-associated kidney disease hold great promise. The single most important diagnostic test to differentiate various forms of kidney disease in HIV-infected patients is a kidney biopsy. The results of treating kidney disease in HIV-infected patients remain unclear, and properly designed randomized controlled trials of the treatment of ICGN with HAART and other approaches are desperately needed.
authors.affiliation: Division of Kidney Urologic and Hematologic Diseases, National Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, MD 20892, USA.
authors.forename: Ajay K
authors.initials: AK
authors.lastname: Rachakonda
authors.forename: Paul L
authors.initials: PL
authors.lastname: Kimmel
mesh_terms: D003449:Cryoglobulinemia / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D015658:HIV Infections / Q000453:epidemiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000276:immunology* / Q000628:therapy; D008181:Lupus Nephritis / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D009404:Nephrotic Syndrome / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D057049:Thrombotic Microangiopathies / Q000453:epidemiology / Q000276:immunology / Q000628:therapy